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The influence of the conformational state of ADP/ATP antiporter on the efficiency of the inhibitory effect of cyclosporine A on the Ca*+-induced 
nonspecific permeability of the inner mitochondrial membrane has been studied. Carboxyatractiloside, the inhibitor of ADP/ATP-antiporter, was 
shown to prevent the cyclosporine A-induced suppression of the nonspecific permeability. The carboxyatractiloside effect was displayed only in 
mitochondria depleted of adenine nucleotides. Bifunctional SH reagent, phenylarsine oxide, was also able to reverse the effect of cyclosporine A. 
The data are consistent with the suggestion that cyclosporine A causes uppression of the nonspecific permeability due to its effect on the ADP/ATP 
antiporter confo~ation. 
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1. INTRODUCTION 
Accumulation of Ca2 + by mitochondria in the 
presence of Pi is known to result in the increase in the 
permeability of the inner mitochondrial membrane for 
substances with M < 1500 [l-3]. Current data f4-7f in- 
dicate that ADPlATP antiporter is the key component 
which takes part in the induction of such a state of 
permeability. Stabilization of the nucleotide binding 
site of ADP/ATP antiporter on the matrix side of the 
inner membrane (m-state) by ADP or bongkrekic acid 
prevents the activation of the nonspecific ~rmeability. 
In contrast, carboxyatractyloside, pyridoxal-S-phos- 
phate and palmitoyl-CoA, stabilizing the nucleotide 
binding site on the cytoplasmic side of the inner mem- 
brane (c-state), exert the opposite effect [4-61. It may be 
proposed that ADP/ATP antiporter either participates 
directly in the formation of the system, which provides 
nonspecific permeability, or regulates its activity. Re- 
cent studies on the reconstituted system, consisting of 
liposomes that carry enriched ADP/ATP antiporter, 
indicate that this carrier could be converted into a 
nonspecific transmembrane channel 171. This argues in 
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favour of the first version. However, the point of view 
that ADP/ATP antiporter directly takes part in the for- 
mation of a system providing the nonspecific 
permeability, is in a certain contradiction with data 
from laboratories of Pfeiffer [2] and Crompton [3]. 
These authors postulating the existence in the inner 
mitochondrial membrane of Ca2 + -dependent pore 
responsible for redistribution of low-M, compounds 
show that the well known immunosuppressor, 
cyclosporine A, is apparently a specific inhibitor of this 
pore. At the same time, cyclosporine A has no apparent 
influence on the activity of ADPfATP antiporter [S]. 
The aim of this study is to investigate the influence of 
the conformational state of ADP/ATP antiporter on 
the efficiency of suppression of the Ca2 ’ -induced 
nonspecific permeability transition by cyclosporine A. 
2. MATERIALS AND METHODS 
Rat liver mitochondria were isolated by differential centrifugation 
[9] in a medium containing 250 mM sucrose, 500 &M EDTA, 5 mM 
Hepes (pH 7.4). The final washing was performed in the same 
medium, but without EDTA. Protein concentration was determined 
by the biuret method using bovine serum albumin as a standard. 
TPP + concentration (TPP +-selective lectrode HO]) and mitochon- 
drial swelting (light scattering at 660 nm) were registered 
simultaneously at the same measuring cell. Ah\lr changes were 
evaluated by the TPP+ distribution between the incubation medium 
and mitochondrial matrix. Mitochondria (0.5 mg/ml) were incubated 
at 26°C in a medium containing 10 mM succinate, 2 eM TPPCl, 2 pM 
rotenone, 10 mM HsPO.,, IO mM Mes-Tris (pH 7.4), plus a sufficient 
amount of sucrose to give a total osmotic strength of 300 mosM. 
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3. RESULTS AND DISCUSSION 
As follows from Fig. 1 (curve 3) the addition of Ca2 + 
to the mitochondrial suspension results in the transient 
drop of A\k due to the accumulation of these ions in the 
mitochondrial matrix. After some lag period a spon- 
taneous decrease in A* occurs. The second phase of the 
A\k decrease is thought to be caused by the opening of 
a nonspecific Ca2+ -dependent pore [l-3]. In accor- 
dance with data from [2,3,8] cyclosporine A completely 
prevents the development of the nonspecific permeabili- 
ty (Fig. 1, curve 1) while having no influence on the 
energy-dependent accumulation of Ca2+ ions and the 
ability of mitochondria to produce ATP (curve 2) [8]. 
As follows from curve 3, cyclosporine A is also able to 
restore the initial permeability of the inner mitochon- 
drial membrane after practically complete mitochon- 
drial deenergization (transition of almost entire 
mitochondrial population into the state of nonspecific 
permeability). Carboxyatractyloside is known to 
facilitate the transition into the state of nonspecific 
permeability, apparently as a result of the stabilization 
of ADP/ATP antiporter in c-state [4-61. However, as 
follows from the comparison of curves 1 and 3, carbox- 
yatractyloside is able to reverse the cyclosporine A ef- 
fect in the only case when mitochondria have been in- 
itially passed through the state of nonspecific 
permeability. These results show that, first, the 
cyclosporine A effect is not due to the direct suppres- 
sion of the nonspecific pore but is mediated through its 
effect on ADP/ATP antiporter, and secondly, for sup- 
pression by cyclosporine A of the nonspecific 
permeability increase, induced by stabilization of 
ADP/ATP antiporter in c-state, the presence of some 
low-M, factor which has been lost after transition into 
the state of nonspecific permeability is required. 
Without this factor carboxyatractyloside provides the 
transition of ADP/ATP antiporter into c-state, thus in- 
ducing the nonspecific permeability even in the presence 
of cyclosporine A. The role of such a factor could be 
played by ADP, which is capable of stabilizing 
ADP/ATP antiporter in m-state. During the mitochon- 
drial transition into the state of nonspecific permeabili- 
ty a release of ADP from the matrix occurs. ADP can 
be removed from the mitochondrial matrix by an ex- 
change for PPi. The ADP/PPi exchange is catalyzed by 
ADP/ATP antiporter and is completely blocked by car- 
boxyatractyloside [11,121. 
As seen in Fig. 2 (curves 1,3) preincubation of 
mitochondria with PPi lowers the efficiency of 
cyclosporine A to suppress the increase in the 
nonspecific permeability. It could be explained by 
reorientation of ADP/ATP antiporter from m- into c- 
state as a result of ADP loss by mitochondria. Carbox- 
yatractyloside completely reverses the inhibitory effect 
of cyclosporine A. This is evident from the observed 
fast decrease in A* (curve 2a) and the activation of the 
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Fig. 1. The influence of cyclosporine A and carboxzyatractyloside on 
the Ca*+-induced A* decrease and oxidative phosphorylation. For 
conditions see section 2. (1,2) In the presence of 0.5 gM cyclosporine 
A; (3) control. Arrows show addition of CaClz (20 nmol/mg protein), 
cyclosporine A, 250 pM ADP (curve 2), 5 pM carboxyatractyloside. 
Fig. 2. The influence of cyclosporine A and carboxyatractyloside on 
the Cal+ -induced A* decrease (a) and high amplitude swelling (b) of 
mitochondria depleted of adenine nucleotides by preincubation with 
PPr. For conditions see section 2. Succinate, Pi and rotenone were 
eliminated from the medium and 5 mM PPi was added. (1) Control; 
(2-4) in the presence of 0.5 gM cyclosporine A. (3) In the absence of 
CATR; (2) CATR was added 2 min after CaClz; (4) 5 PM CATR was 
added to the incubation medium beforehand. Arrows show addition 
of CaClz (25 nmol/mg protein), 5 pM carboxyatractyloside, 2 pM 
rotenone, 10 mM succinate, 5 mM P,-Tris. 
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high amplitude mitochondrial swelling (curve 2b). At 
the same time, at the inhibition of the ADP/PPi ex- 
change by carboxyatractiloside addition simultaneously 
with mitochondria, cyclosporine A completely blocks 
the Ca2 + -induced nonspecific permeability (curves 
4a,4b). 
The data presented allow one to assume, first, that 
the cyclosporine A effect is mediated through its in- 
fluence on ADP/ATP antiporter, and secondly, 
adenine nucleotides are obligatory components for 
displaying the effect of cyclosporine A. In this respect, 
of great interest are the data of Kramer [7] showing that 
modification of two SH groups of ADP/ATP an- 
tiporter, reconstituted into liposomes, results in the in- 
crease in ionic permeability of liposomal membranes. 
On the basis of these data it is possible to predict that 
the suppression of the mitochondrial nonspecific 
permeability by cyclosporine A should be reversed by 
the reagents modifying SH groups, even without 
removing the endogenous adenine nucleotides. Really, 
as seen from Fig. 3, the addition of hydrophobic 
bifunctional SH reagent, PhAsO, completely reverses 
the suppression of the nonspecific permeability by 
cyclosporine A. The effect of PhAsO is explained by the 
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Fig. 3. The influence of PhAsO and cyclosporine A on the 
Ca* ‘-induced Af decrease (a) and high amplitude swelling of 
mitochondria (b). For conditions see section 2. (1) Control; (2) in the 
presence of 1 pM cyclosporine A. Arrows show the addition of CaClz 
Fig. 4. The influence of N-ethylmaleimide and mersalyl on the 
PhAsO-induced A8 decrease (a) and high amplitude mitochondrial 
swelling (b). For conditions see section 2. (l-3) In the presence of 0.5 
pM cyclosporine A; (1) control; (2) with mersalyl; (3) with N- 
ethylmaleimide (NEM). Arrows show the addition of 25 pM PhAsO, 
(30 nmol/mg protein), 15 pM PhAsO. mersalyl (20 nmol/mg protein), 50 pM N-ethylmaleimide. 
cross-linking of two SH groups in a hydrophobic moie- 
ty of the membrane. This is proved by the complete 
removal of PhAsO effect by the hydrophobic 
monofunctional SH reagent, N-ethylmaleimide, but not 
by hydrophilic mersalyl (Fig. 4). The above fact ex- 
cludes, in particular, the possibility of inhibition of the 
nonspecific permeability by N-ethylmaleimide through 
its binding with Pi/OH - antiporter and the resulting 
blockade of Pi redistribution across the inner mitochon- 
drial membrane. But it is worth noting that some dif- 
ference in the activation of the nonspecific permeability 
by PhAsO is observed in the absence and presence of 
mersalyl (curves la,b; 2a,b). In the presence of mersalyl 
the phase of a partial mitochondrial de-energization, 
not accompanied by the high amplitude mitochondrial 
swelling, precedes the activation of the nonspecific 
permeability. One of the possible explanations for this 
fact may be that mersalyl modifies an access to factor B 
SH groups, of which the cross-linking by PhAsO in- 
duces the H+ leakage (not coupled to ATP synthesis) 
through F, of the ATP-synthase complex [13]. 
The results presented above show that, first, the sup- 
pression of the nonspecific permeability by 
cyclosporine A is mediated through its influence on 
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ADPlATP antiporter; secondly, our data together with 
data of Kramer [7] allow to suppose that ADPfATP an- 
tiporter itseIf is able under certain conditions to form a 
hydrophylic pore, providing the permeability of the in- 
ner mitochondrial membrane for low-M, compounds. 
However, to confirm the last statement in experiments 
with reconstituted systems it is necessary to exclude the 
possibiIity that the system responsible for the 
nonspecific permeability does not co-purify with 
ADP/ATP antiporter because the usual impurity of 
isolated antiporter is about 25% [ 141. 
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